Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design

References

• Amaral M, Martins AS, Catarino J, et al. (2020). How can biomolecules improve mucoadhesion of oral insulin? A comprehensive insight using ex-vivo, in silico, and in vivo models. Biomolecules 10:675.
   PubMed Web of Science ®Google Scholar
• Ashar A, Bhatti IA, Siddique T, et al. (2021). Integrated hydrothermal assisted green synthesis of ZnO nano discs and their water purification efficiency together with antimicrobial activity. J Mater Res Technol 15:6901–17.
   Google Scholar
• Bally L, Thabit H, Hovorka R. (2017). Finding the right route for insulin delivery–an overview of implantable pump therapy. Expert Opin Drug Deliv 14:1103–11.
   PubMed Web of Science ®Google Scholar
• Ban C, Jo M, Lim S, Choi YJ. (2018). Control of the gastrointestinal digestion of solid lipid nanoparticles using PEGylated emulsifiers. Food Chem 239:442–52.
   PubMed Web of Science ®Google Scholar
• Bashyal S, Seo J-E, Choi YW, Lee S. (2021). Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach. J Control Release 338:644–61.
   PubMed Web of Science ®Google Scholar
• Chamieh J, Tarrat AD, Doudou C, et al. (2019). Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis. Int J Pharm 559:228–34.
   PubMedGoogle Scholar
• Cho HJ, Lee DW, Marasini N, et al. (2013). Optimization of self-microemulsifying drug delivery system for telmisartan using Box–Behnken design and desirability function. J Pharm Pharmacol 65:1440–50.
   PubMed Web of Science ®Google Scholar
• Coronado M, Segadães AM, Andrés A. (2014). Combining mixture design of experiments with phase diagrams in the evaluation of structural ceramics containing foundry by-products. Appl Clay Sci 101:390–400.
   Web of Science ®Google Scholar
• Cryan S-A. (2005). Carrier-based strategies for targeting protein and peptide drugs to the lungs. Aaps J 7:E20–E41.
   PubMed Web of Science ®Google Scholar
• Dai W-G, Dong LC. (2007). Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing. Int J Pharm 336:58–66.
   PubMed Web of Science ®Google Scholar
• Damgé C, Maincent P, Ubrich N. (2007). Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 117:163–70.
   PubMed Web of Science ®Google Scholar
• Dhaval M, Vaghela P, Patel K, et al. (2022). Lipid-based emulsion drug delivery systems—a comprehensive review. Drug Deliv Transl Res 12:1616–39.
   PubMed Web of Science ®Google Scholar
• Fernandez S, Jannin V, Rodier J-D, et al. (2007). Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol®, medium chain glycerides and PEG esters. Biochim Biophys Acta Mol Cell Biol Lipids 1771:633–40.
   PubMed Web of Science ®Google Scholar
• Goo YT, Sa C-K, Kim MS, et al. (2022). Enhanced dissolution and bioavailability of revaprazan using self-nanoemulsifying drug delivery system. Pharm Dev Technol 27:414–24.
   PubMed Web of Science ®Google Scholar
• Griesser J, Hetényi G, Moser M, et al. (2017). Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm 520:267–74.
   PubMed Web of Science ®Google Scholar
• Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 58:173–82.
   PubMed Web of Science ®Google Scholar
• Haddadzadegan S, Dorkoosh F, Bernkop-Schnurch A. (2022). Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 182:114097.
   PubMed Web of Science ®Google Scholar
• Hintzen F, Perera G, Hauptstein S, et al. (2014). In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm 472:20–6.
   PubMed Web of Science ®Google Scholar
• Kale AA, Patravale VB. (2008). Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech 9:191–6.
   PubMed Web of Science ®Google Scholar
• Karamanidou T, Karidi K, Bourganis V, et al. (2015). Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur J Pharm Biopharm 97:223–9.
   PubMed Web of Science ®Google Scholar
• Lee DH, Yeom DW, Song YS, et al. (2015). Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS). Int J Pharm 478:341–7.
   PubMed Web of Science ®Google Scholar
• Lee DW, Marasini N, Poudel BK, et al. (2014). Application of Box–Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS). J Microencapsul 31:31–40.
   PubMed Web of Science ®Google Scholar
• Li P, Tan A, Prestidge CA, et al. (2014). Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Int J Pharm 477:390–8.
   PubMed Web of Science ®Google Scholar
• Liao H, Gao Y, Lian C, et al. (2019). Oral absorption and lymphatic transport of baicalein following drug–phospholipid complex incorporation in self-microemulsifying drug delivery systems. Int J Nanomed 14:7291–306.
   PubMed Web of Science ®Google Scholar
• Liu J, Werner U, Funke M, et al. (2019). SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats. Int J Pharm 560:377–84.
   PubMedGoogle Scholar
• Mahmood A, Bernkop-Schnürch A. (2019). SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev 142:91–101.
   PubMed Web of Science ®Google Scholar
• Menzel C, Holzeisen T, Laffleur F, et al. (2018). In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide. J Controll Release 277:165–72.
   PubMed Web of Science ®Google Scholar
• Mura P, Furlanetto S, Cirri M, et al. (2005). Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design. J Pharm Biomed Anal 37:65–71.
   PubMed Web of Science ®Google Scholar
• Nazir I, Asim MH, Dizdarević A, Bernkop-Schnürch A. (2019). Self-emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release. Int J Pharm 561:197–205.
   PubMedGoogle Scholar
• Noh G, Keum T, Bashyal S, et al. (2022). Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals. J Pharm Investig 52:75–93.
   Web of Science ®Google Scholar
• Park SY, Jin CH, Goo YT, et al. (2021). Supersaturable self-microemulsifying drug delivery system enhances dissolution and bioavailability of telmisartan. Pharm Dev Technol 26:60–8.
   PubMed Web of Science ®Google Scholar
• Patel MH, Sawant KK. (2019). Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: in vitro, Caco-2 cell line and in vivo evaluation. Eur J Pharm Sci 138:105027.
   PubMed Web of Science ®Google Scholar
• Peres DDA, Ariede MB, Candido TM, et al. (2017). Quality by design (QbD), Process Analytical Technology (PAT), and design of experiment applied to the development of multifunctional sunscreens. Drug Dev Ind Pharm 43:246–56.
   PubMed Web of Science ®Google Scholar
• Pillai O, Panchagnula R. (2001). Insulin therapies – past, present and future. Drug Discov Today 6:1056–61.
   PubMed Web of Science ®Google Scholar
• Quarta E, Chierici V, Flammini L, et al. (2020). Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats. J Control Release 323:412–20.
   PubMed Web of Science ®Google Scholar
• Ristroph KD, Prud’homme RK. (2019). Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv 1:4207–37.
   PubMed Web of Science ®Google Scholar
• Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM. (2007). Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J Pharm Pharm Sci 10:319–31.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. (2007). Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8:3054–60.
   PubMed Web of Science ®Google Scholar
• Shahzadi I, Nazir I, Phan TNQ, Bernkop-Schnürch A. (2020). About the impact of superassociation of hydrophobic ion pairs on membrane permeability. Eur J Pharm Biopharm 151:1–8.
   PubMed Web of Science ®Google Scholar
• Shrestha N, Araújo F, Shahbazi MA, et al. (2016). Thiolation and cell-penetrating peptide surface functionalization of porous silicon nanoparticles for oral delivery of insulin. Adv Funct Mater 26:3405–16.
   Web of Science ®Google Scholar
• Son HY, Chae BR, Choi JY, et al. (2018). Optimization of self-microemulsifying drug delivery system for phospholipid complex of telmisartan using D-optimal mixture design. PLoS One 13:e0208339.
   PubMed Web of Science ®Google Scholar
• Sun S, Cui F, Kawashima Y, et al. (2008). A novel insulin-sodium oleate complex for oral administration: preparation, characterization and in vivo evaluation. J Drug Deliv Sci Technol 18:239–43.
   Web of Science ®Google Scholar
• Sun S, Liang N, Kawashima Y, et al. (2011). Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin. Int J Nanomed 6:3049–56.
   PubMed Web of Science ®Google Scholar
• Sun S, Liang N, Yamamoto H, et al. (2015). pH-sensitive poly (lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin. Int J Nanomed 10:3489–98.
   PubMed Web of Science ®Google Scholar
• Suram D, Veerabrahma K. (2022). Design and development of solid SMEDDS and liquisolid formulations of lovastatin, for improved drug dissolution and in vivo effects – a pharmacokinetic and pharmacodynamic assessment. AAPS PharmSciTech 23:123.
   PubMed Web of Science ®Google Scholar
• Tang J, Bai Y, Chen X. (2021). An investigation of inorganic fillers on rheological properties and tensile strength of epoxy repair coating using mixture design method. Constr Build Mater 307:124866.
   Web of Science ®Google Scholar
• Varanda C, Portugal I, Ribeiro J, et al. (2017). Optimization of bitumen formulations using mixture design of experiments (MDOE). Constr Build Mater 156:611–20.
   Web of Science ®Google Scholar
• Verma S, Goand UK, Husain A, et al. (2021). Challenges of peptide and protein drug delivery by oral route: current strategies to improve the bioavailability. Drug Dev Res 82:927–44.
   PubMed Web of Science ®Google Scholar
• Vithani K, Hawley A, Jannin V, et al. (2017). Inclusion of digestible surfactants in solid SMEDDS formulation removes lag time and influences the formation of structured particles during digestion. Aaps J 19:754–64.
   PubMed Web of Science ®Google Scholar
• Weng T, Qi J, Lu Y, et al. (2014). The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations. J Nanobiotechnol 12:39.
   PubMed Web of Science ®Google Scholar
• Wibel R, Friedl JD, Zaichik S, Bernkop-Schnürch A. (2020). Hydrophobic ion pairing (HIP) of (poly) peptide drugs: benefits and drawbacks of different preparation methods. Eur J Pharm Biopharm 151:73–80.
   PubMed Web of Science ®Google Scholar
• Xia F, Chen Z, Zhu Q, et al. (2021). Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route. Acta Pharm Sin B 11:1010–20.
   PubMed Web of Science ®Google Scholar
• Xiong XY, Li YP, Li ZL, et al. (2007). Vesicles from pluronic/poly (lactic acid) block copolymers as new carriers for oral insulin delivery. J Controll Release 120:11–7.
   PubMed Web of Science ®Google Scholar
• Yao J, Lu Y, Zhou JP. (2008). Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats. J Pharm Pharm Sci 11:22–9.
   PubMedGoogle Scholar
• Yeom DW, Song YS, Kim SR, et al. (2015). Development and optimization of a self-microemulsifying drug delivery system for ator vastatin calcium by using D-optimal mixture design. Int J Nanomedicine 10:3865–77.
   PubMed Web of Science ®Google Scholar
• Yin Y-M, Cui F-D, Mu C-F, et al. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Controll Release 140:86–94.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wen X, Dai Y, Xia Y. (2019). Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex. Int J Nanomedicine 14:7095–106.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping QN, Huang GH, Xu WF. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 294:247–59.
   PubMed Web of Science ®Google Scholar
• Zhang Q, He N, Zhang L, et al. (2012). The in vitro and in vivo study on self-nanoemulsifying drug delivery system (SNEDDS) based on insulin-phospholipid complex. J Biomed Nanotechnol 8:90–7.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang X, Xue H, et al. (2021). Determination and comparison of the solubility, oil–water partition coefficient, intestinal absorption, and biliary excretion of carvedilol enantiomers. AAPS PharmSciTech 22:43.
   PubMed Web of Science ®Google Scholar
• Zhang T, Tang JZ, Fei X, et al. (2021). Can nanoparticles and nano–protein interactions bring a bright future for insulin delivery? Acta Pharm Sin B 11:651–67.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zu Y, Zu S, et al. (2010). Insulin nanoparticles for transdermal delivery: preparation and physicochemical characterization and in vitro evaluation. Drug Dev Ind Pharm 36:1177–85.
   PubMed Web of Science ®Google Scholar
• Zupančič O, Rohrer J, Thanh Lam H, et al. (2017). Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery. Drug Dev Ind Pharm 43:1694–702.
   PubMed Web of Science ®Google Scholar